BioCentury RFK Jr.'s peptide deregulation threatens the foundations of drug safety The FDA scheduled a hearing on peptides and the implications could be significant for prescribers and FDA takes first step in possible reversal of ban on some peptides The Washington Post Big news in the peptide world. , The FDA has scheduled a formal hearing in July to review 7 peptides including BPC 157 and TB 500 for legal compounding. , This isnt approval. But its Why would a patient trust a peptide more than a statin? STAT Regeneration or Risk? A Narrative Review of BPC 157 for Musculoskeletal Healing Current Reviews in Musculoskeletal Medicine Springer Nature Link